AstraZeneca PLC Dividend History (AZN)
🤑 AstraZeneca PLC has distributed a total of 43 dividends from 2003 to 2024
📈 During this 21 period their dividend has seen a 96.08% increase in the payout amount
About AstraZeneca PLC
AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Established in 1999 through the merger of Sweden's Astra AB and the UK's Zeneca Group, the company has grown to become a major player in the pharmaceutical industry. As of 2023, Pascal Soriot serves as the CEO, a position he has held since 2012, helping drive innovation and growth within the company. Headquartered in Cambridge, UK, AstraZeneca operates in over 100 countries, with a significant commitment to research and development, boasting several R&D centers worldwide. In recent years, the company has gained attention for its role in developing a COVID-19 vaccine and its ongoing efforts in oncological research. AstraZeneca reported a revenue of approximately $37.4 billion in 2022, reflecting its global impact on healthcare and its continuous push towards addressing unmet medical needs.
Sanofi, a global pharmaceutical company, has significantly increased its investments in Beijing E-Town over the past three decades, reflecting the area's favorable business environment. The article highlights the exceptional services and support provided by E-Town, which have earned the confidence of multinational corporations.
GlobeNewswire Inc. · Published on Thu Dec 05 2024The report discusses emerging therapies for non-cystic fibrosis bronchiectasis, a chronic lung condition, including Brensocatib and HSK31858, which are in advanced clinical trials and show promise in reducing inflammation and improving patient outcomes.
GlobeNewswire Inc. · Published on Thu Nov 28 2024The global personalized medicines market is expected to reach a value of USD 1352.81 Billion by 2031, driven by the growing demand for innovative therapies and advancements in genetic technology. The market is dominated by hospitals and clinical care, and North America leads the market due to favorable regulatory frameworks.
Benzinga · Published on Wed Nov 27 2024Previous Payouts (43)
The most recent dividend AstraZeneca PLC paid out was on September 9, 2024 (87 days ago) for $0.5 per share
Pay Date | Amount |
---|---|
September 9, 2024 | $0.5 |
March 25, 2024 | $0.985 |
September 11, 2023 | $0.465 |
March 27, 2023 | $0.985 |
September 12, 2022 | $0.465 |
March 28, 2022 | $0.985 |
September 13, 2021 | $0.45 |
March 29, 2021 | $0.95 |
September 14, 2020 | $0.45 |
March 30, 2020 | $0.95 |
September 9, 2019 | $0.45 |
March 27, 2019 | $0.95 |
September 10, 2018 | $0.45 |
March 19, 2018 | $0.95 |
September 11, 2017 | $0.45 |
March 20, 2017 | $0.95 |
September 12, 2016 | $0.45 |
March 21, 2016 | $0.95 |
September 14, 2015 | $0.45 |
March 23, 2015 | $1.9 |
September 15, 2014 | $0.9 |
March 24, 2014 | $1.9 |
September 16, 2013 | $0.9 |
March 18, 2013 | $1.9 |
September 10, 2012 | $0.9 |
March 19, 2012 | $1.95 |
September 12, 2011 | $0.85 |
March 14, 2011 | $1.85 |
September 13, 2010 | $0.7 |
March 15, 2010 | $1.71 |
September 14, 2009 | $0.59 |
March 16, 2009 | $1.5 |
September 15, 2008 | $0.55 |
March 17, 2008 | $1.35 |
September 17, 2007 | $0.52 |
March 19, 2007 | $1.23 |
September 18, 2006 | $0.49 |
March 20, 2006 | $0.92 |
September 19, 2005 | $0.38 |
March 21, 2005 | $0.645 |
September 20, 2004 | $0.295 |
April 6, 2004 | $0.54 |
October 6, 2003 | $0.255 |
Dividend data last updated Thu, 05 Dec 2024 17:31:07 GMT UTC